Background
==========

Several studies suggest that CD4^+^ T-cell count (CD4) is important in pathogenesis of human papillomavirus (HPV) infection in HIV-positive patients including HPV clearance. CD4 dynamics as well as other co-factors such as highly active antiretroviral therapy (HAART), HIV-1 RNA viral load (VL), demographics, behavioral risks and, clinical diagnosis allows for predicting the absolute probabilities of HPV clearance/persistence. The modeling approach allows for the utilization of complete datasets and does not require any additional essential assumptions about missing information and possible violations in study design.

Materials and methods
=====================

We analyzed 266 HIV-1 positive adolescent girls from the Reaching for Excellence in Adolescent Care and Health (REACH) cohort. At enrollment and every 6 months thereafter, cervical lavage samples were tested for HPV using MY09/MY11/HMB01-based PCR and 30 HPV type-specific probes. HIV-related clinical data and risk factors were recorded every 3 months. For analytic purposes, HPV types were categorized according to phylogenetic patterns into (1) 16/16-like, (2) 18/18-like, (3) other high risk (56/56-like), and (4) low risk. HPV clearance was defined by the absence of type-specific infection for two subsequent visits after infection. Maximum likelihood estimates based on the logistic-type model were developed for 3-month reconstructed probabilities of HPV clearance/persistent with CD4, VL, and HAART as the main predictors at the moment of examination.

Results
=======

Figure [1A](#F1){ref-type="fig"} presents the clearance probability for HIV-positive patients depending on CD4 for HPV16/16-like, HPV18/18-like, HPV56/56-like, and low-risk HPV. HPV16/16-like infection has the lowest chance to be cleared by host at low CD4 levels. The probability of 3-month clearance was less than 20% for patients with CD4 \<200, but increased gradually with CD4 increase but overall was slower than for HPV18/18-like, other high-risk, and low-risk HPV. Additionally, the 3-D plot in Figure [1B](#F1){ref-type="fig"} describes CD4 and log (VL) as predictors of probability of HPV16/16-like clearance: the lowest CD4 levels together with the highest VL were significant predictors for HPV persistence. The multiplicative effect of HAART showed tendency to decrease on HPV16/16-like clearance probability with increasing CD4 levels.
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Conclusion
==========

This approach could extend opportunities to understand the associations between CD4, VL, and HAART to develop the comprehensive approach to individualized prediction of HPV infection persistence/clearance in HIV-positive patients.
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